Skip to content

Clinical trials

Phase 2 Multiple Endocrine Neoplasia Type 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20071
20091
20142
20182
20191
20202
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Premier Research2
Astellas Pharma Inc1
Beth Israel Deaconess Medical Center1
M.D. Anderson Cancer Center1
MedSIR1
Medical College of Wisconsin1
National Center for Complementary and Integrative Health (NCCIH)1
Shehzad Basaria, M.D.1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 113
Prostatic Neoplasms3
Breast Neoplasms2
Neuroendocrine Tumors2
Somatostatinoma2
Adenocarcinoma1
Alcoholism1
Epilepsy1
Erectile Dysfunction1
Glucagonoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.